
In first open-label phase 3 data from the ADEPT program, KarXT cut hallucination and delusion scores in Alzheimer disease psychosis, with no new safety signals.
Tell us more about how you use social media as a mental health clinician!
We want to learn more about how YOU use social media as a clinician! Over the next couple of days, we'll release a series of polls to gauge how best to connect with our readers. Check out the third one here:
What Social Media Platform Do You Use for News and Updates?




